Par Pharmaceutical Hit With Securities Suits

Law360, New York (July 21, 2006, 12:00 AM EDT) -- Drugmaker Par Pharmaceutical Companies, Inc. has been hit with a lawsuit alleging the company misled investors and overstated its revenue by at least $55 million.

The lawsuit, filed in federal court in Manhattan, seeks class action status, and lists the New Jersey-based company, one current executive and one former executive as defendants.

David Rosenfeld, an attorney for the plaintiff, was confident about his client’s prospects, saying Par’s July 5 admission that it had overstated its earnings and would have to restate financial results for 2004, 2005...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.